Presentation Information
[C1-06]Company introduction
*Akihito Sawada1, Kazuyuki Ikeda1 (1. Meiji Seika Pharma Co., Ltd. (Japan))
Keywords:
Infection disease,Vaccine,Covid-19
Login required to view
Comment
To browse or post comments, you must log in.Log in